Changing the way
we prevent infectious disease.
Introducing a new approach to the design, scale-up, and storage of temperature-stable vaccines against influenza.
Our Mission
ImmunoNanoMed is a start-up with business interests in the development of particle-based vaccines against infectious diseases. The first step to demonstrating this innovate approach will be through developing particle-based vaccines against influenza that are single dose, long lasting, and room temperature-stable.
Our Mission
Discover how we’re transforming the development of seasonal flu vaccines.
Our Technology
Discover our patented technology for producing room temperature-stable, biodegradable flu vaccines.
Our Roadmap
Follow our journey as we commercialize the next generation of flu vaccines.
Our Partners
We aim to improve protection for all all ages.
Vaccines tend to be less effective in older populations, who are at higher risk for severe complications from influenza. We aim to improve protection in these populations.
ImmunoNanoMed 